HEADER VIRAL PROTEIN 21-JAN-22 7WOC TITLE LOCALLY REFINED REGION OF SARS-COV-2 SPIKE IN COMPLEX WITH IGG 553-60 COMPND MOL_ID: 1; COMPND 2 MOLECULE: SPIKE PROTEIN S1; COMPND 3 CHAIN: C; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: MAB60 VH; COMPND 7 CHAIN: A; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 3; COMPND 10 MOLECULE: MAB60 VL; COMPND 11 CHAIN: B; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 3 2; SOURCE 4 ORGANISM_TAXID: 2697049; SOURCE 5 GENE: S, 2; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_TAXID: 9606; SOURCE 11 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 12 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 13 MOL_ID: 3; SOURCE 14 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 15 ORGANISM_TAXID: 9606; SOURCE 16 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 9606 KEYWDS SARS-COV-2, SPIKE, ANTIBODY, VIRAL PROTEIN EXPDTA ELECTRON MICROSCOPY AUTHOR W.Q.ZHAN,X.ZHANG,Z.G.CHEN,L.SUN REVDAT 6 13-NOV-24 7WOC 1 REMARK REVDAT 5 14-SEP-22 7WOC 1 JRNL REVDAT 4 07-SEP-22 7WOC 1 JRNL REVDAT 3 17-AUG-22 7WOC 1 JRNL REVDAT 2 27-JUL-22 7WOC 1 TITLE REVDAT 1 20-JUL-22 7WOC 0 JRNL AUTH W.ZHAN,X.TIAN,X.ZHANG,S.XING,W.SONG,Q.LIU,A.HAO,Y.HU, JRNL AUTH 2 M.ZHANG,T.YING,Z.CHEN,F.LAN,L.SUN JRNL TITL STRUCTURAL STUDY OF SARS-COV-2 ANTIBODIES IDENTIFIES A JRNL TITL 2 BROAD-SPECTRUM ANTIBODY THAT NEUTRALIZES THE OMICRON VARIANT JRNL TITL 3 BY DISASSEMBLING THE SPIKE TRIMER. JRNL REF J.VIROL. V. 96 48022 2022 JRNL REFN ESSN 1098-5514 JRNL PMID 35924918 JRNL DOI 10.1128/JVI.00480-22 REMARK 2 REMARK 2 RESOLUTION. 3.35 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : NULL REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.350 REMARK 3 NUMBER OF PARTICLES : 88701 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 7WOC COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 24-JAN-22. REMARK 100 THE DEPOSITION ID IS D_1300027120. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : SPIKE WITH MAB15 REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 8.00 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K3 BIOQUANTUM (6K X REMARK 245 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 1200.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 2500.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 6100.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 135 REMARK 465 LYS A 136 REMARK 465 SER A 137 REMARK 465 THR A 138 REMARK 465 SER A 139 REMARK 465 GLY A 140 REMARK 465 GLY A 141 REMARK 465 THR A 142 REMARK 465 PRO A 192 REMARK 465 SER A 193 REMARK 465 SER A 194 REMARK 465 SER A 195 REMARK 465 LEU A 196 REMARK 465 GLY A 197 REMARK 465 THR A 198 REMARK 465 GLN A 199 REMARK 465 LYS A 221 REMARK 465 SER A 222 REMARK 465 CYS A 223 REMARK 465 ASP A 224 REMARK 465 LYS A 225 REMARK 465 THR A 226 REMARK 465 GLY B 213 REMARK 465 GLU B 214 REMARK 465 CYS B 215 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 SER B 204 OG REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN C 487 15.37 59.81 REMARK 500 ASN B 31 49.24 -94.08 REMARK 500 ALA B 52 -0.09 66.35 REMARK 500 ASP B 152 -13.66 71.22 REMARK 500 ASN B 153 -28.45 -141.72 REMARK 500 ALA B 154 -170.95 -171.85 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-32648 RELATED DB: EMDB REMARK 900 S-MAB60 NRAB1 LOCAL-REFINED MAP DBREF 7WOC C 334 527 UNP P0DTC2 SPIKE_SARS2 334 527 DBREF 7WOC A 1 226 PDB 7WOC 7WOC 1 226 DBREF 7WOC B 1 215 PDB 7WOC 7WOC 1 215 SEQRES 1 C 194 ASN LEU CYS PRO PHE GLY GLU VAL PHE ASN ALA THR ARG SEQRES 2 C 194 PHE ALA SER VAL TYR ALA TRP ASN ARG LYS ARG ILE SER SEQRES 3 C 194 ASN CYS VAL ALA ASP TYR SER VAL LEU TYR ASN SER ALA SEQRES 4 C 194 SER PHE SER THR PHE LYS CYS TYR GLY VAL SER PRO THR SEQRES 5 C 194 LYS LEU ASN ASP LEU CYS PHE THR ASN VAL TYR ALA ASP SEQRES 6 C 194 SER PHE VAL ILE ARG GLY ASP GLU VAL ARG GLN ILE ALA SEQRES 7 C 194 PRO GLY GLN THR GLY LYS ILE ALA ASP TYR ASN TYR LYS SEQRES 8 C 194 LEU PRO ASP ASP PHE THR GLY CYS VAL ILE ALA TRP ASN SEQRES 9 C 194 SER ASN ASN LEU ASP SER LYS VAL GLY GLY ASN TYR ASN SEQRES 10 C 194 TYR LEU TYR ARG LEU PHE ARG LYS SER ASN LEU LYS PRO SEQRES 11 C 194 PHE GLU ARG ASP ILE SER THR GLU ILE TYR GLN ALA GLY SEQRES 12 C 194 SER THR PRO CYS ASN GLY VAL GLU GLY PHE ASN CYS TYR SEQRES 13 C 194 PHE PRO LEU GLN SER TYR GLY PHE GLN PRO THR ASN GLY SEQRES 14 C 194 VAL GLY TYR GLN PRO TYR ARG VAL VAL VAL LEU SER PHE SEQRES 15 C 194 GLU LEU LEU HIS ALA PRO ALA THR VAL CYS GLY PRO SEQRES 1 A 226 GLN VAL GLN LEU VAL GLN SER GLY ALA GLU VAL LYS ARG SEQRES 2 A 226 PRO GLY SER SER VAL LYS VAL SER CYS LYS ALA SER GLY SEQRES 3 A 226 ASP THR PHE ILE ASN TYR ALA PHE SER TRP VAL ARG GLN SEQRES 4 A 226 ALA PRO GLY GLN GLY LEU GLU TRP MET GLY ARG ILE ILE SEQRES 5 A 226 PRO ILE LEU ASP ILE ALA HIS TYR ALA GLN LYS PHE GLN SEQRES 6 A 226 GLY ARG LEU THR ILE THR ALA ASP LYS SER THR ASP THR SEQRES 7 A 226 ALA TYR MET GLU LEU THR SER LEU LYS SER ASP ASP THR SEQRES 8 A 226 ALA VAL TYR PHE CYS ALA ARG VAL PHE ARG GLY SER GLN SEQRES 9 A 226 TYR TRP PHE ASP PRO TRP GLY GLN GLY THR LEU VAL THR SEQRES 10 A 226 VAL SER SER ALA SER THR LYS GLY PRO SER VAL PHE PRO SEQRES 11 A 226 LEU ALA PRO SER SER LYS SER THR SER GLY GLY THR ALA SEQRES 12 A 226 ALA LEU GLY CYS LEU VAL LYS ASP TYR PHE PRO GLU PRO SEQRES 13 A 226 VAL THR VAL SER TRP ASN SER GLY ALA LEU THR SER GLY SEQRES 14 A 226 VAL HIS THR PHE PRO ALA VAL LEU GLN SER SER GLY LEU SEQRES 15 A 226 TYR SER LEU SER SER VAL VAL THR VAL PRO SER SER SER SEQRES 16 A 226 LEU GLY THR GLN THR TYR ILE CYS ASN VAL ASN HIS LYS SEQRES 17 A 226 PRO SER ASN THR LYS VAL ASP LYS ARG VAL GLU PRO LYS SEQRES 18 A 226 SER CYS ASP LYS THR SEQRES 1 B 215 GLU ILE VAL LEU THR GLN SER PRO GLY THR LEU SER LEU SEQRES 2 B 215 SER PRO GLY GLU ARG ALA THR LEU SER CYS ARG ALA SER SEQRES 3 B 215 GLN SER ILE ASN ASN ARG HIS LEU ALA TRP TYR GLN GLN SEQRES 4 B 215 LYS ARG GLY GLN ALA PRO ARG PHE LEU ILE TYR GLY ALA SEQRES 5 B 215 ALA SER ARG ALA THR GLY ILE PRO ASP ARG PHE SER GLY SEQRES 6 B 215 SER GLY SER GLY THR ASP PHE THR LEU THR ILE SER ARG SEQRES 7 B 215 LEU GLU PRO GLU ASP PHE ALA VAL TYR TYR CYS GLN GLN SEQRES 8 B 215 TYR GLY SER SER PRO PRO THR PHE GLY GLN GLY THR LYS SEQRES 9 B 215 VAL GLU ILE LYS ARG THR VAL ALA ALA PRO SER VAL PHE SEQRES 10 B 215 ILE PHE PRO PRO SER ASP GLU GLN LEU LYS SER GLY THR SEQRES 11 B 215 ALA SER VAL VAL CYS LEU LEU ASN ASN PHE TYR PRO ARG SEQRES 12 B 215 GLU ALA LYS VAL GLN TRP LYS VAL ASP ASN ALA LEU GLN SEQRES 13 B 215 SER GLY ASN SER GLN GLU SER VAL THR GLU GLN ASP SER SEQRES 14 B 215 LYS ASP SER THR TYR SER LEU SER SER THR LEU THR LEU SEQRES 15 B 215 SER LYS ALA ASP TYR GLU LYS HIS LYS VAL TYR ALA CYS SEQRES 16 B 215 GLU VAL THR HIS GLN GLY LEU SER SER PRO VAL THR LYS SEQRES 17 B 215 SER PHE ASN ARG GLY GLU CYS HET NAG C 601 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 4 NAG C8 H15 N O6 HELIX 1 AA1 TYR C 365 ASN C 370 1 6 HELIX 2 AA2 LYS C 386 LEU C 390 5 5 HELIX 3 AA3 ASP C 405 VAL C 407 5 3 HELIX 4 AA4 LYS C 417 ASN C 422 1 6 HELIX 5 AA5 LYS A 87 THR A 91 5 5 HELIX 6 AA6 SER B 122 LYS B 127 1 6 HELIX 7 AA7 ALA B 185 HIS B 190 1 6 SHEET 1 AA1 5 ASN C 354 ILE C 358 0 SHEET 2 AA1 5 ASN C 394 ARG C 403 -1 O VAL C 395 N ILE C 358 SHEET 3 AA1 5 PRO C 507 GLU C 516 -1 O VAL C 510 N PHE C 400 SHEET 4 AA1 5 GLY C 431 ASN C 437 -1 N ILE C 434 O VAL C 511 SHEET 5 AA1 5 THR C 376 TYR C 380 -1 N TYR C 380 O GLY C 431 SHEET 1 AA2 2 CYS C 361 VAL C 362 0 SHEET 2 AA2 2 VAL C 524 CYS C 525 1 O CYS C 525 N CYS C 361 SHEET 1 AA3 2 LEU C 452 ARG C 454 0 SHEET 2 AA3 2 LEU C 492 SER C 494 -1 O GLN C 493 N TYR C 453 SHEET 1 AA4 2 TYR C 473 GLN C 474 0 SHEET 2 AA4 2 CYS C 488 TYR C 489 -1 O TYR C 489 N TYR C 473 SHEET 1 AA5 4 VAL A 5 GLN A 6 0 SHEET 2 AA5 4 VAL A 20 LYS A 23 -1 O LYS A 23 N VAL A 5 SHEET 3 AA5 4 THR A 78 LEU A 83 -1 O ALA A 79 N CYS A 22 SHEET 4 AA5 4 LEU A 68 ASP A 73 -1 N THR A 69 O GLU A 82 SHEET 1 AA6 5 ILE A 57 TYR A 60 0 SHEET 2 AA6 5 LEU A 45 ILE A 52 -1 N ILE A 52 O ILE A 57 SHEET 3 AA6 5 PHE A 34 GLN A 39 -1 N PHE A 34 O ILE A 51 SHEET 4 AA6 5 ALA A 92 ALA A 97 -1 O PHE A 95 N VAL A 37 SHEET 5 AA6 5 THR A 114 VAL A 116 -1 O THR A 114 N TYR A 94 SHEET 1 AA7 4 SER A 127 PHE A 129 0 SHEET 2 AA7 4 ALA A 144 LYS A 150 -1 O LYS A 150 N SER A 127 SHEET 3 AA7 4 LEU A 185 THR A 190 -1 O VAL A 189 N LEU A 145 SHEET 4 AA7 4 HIS A 171 THR A 172 -1 O HIS A 171 N VAL A 188 SHEET 1 AA8 3 VAL A 157 VAL A 159 0 SHEET 2 AA8 3 ILE A 202 HIS A 207 -1 O ASN A 206 N THR A 158 SHEET 3 AA8 3 ASP A 215 ARG A 217 -1 N LYS A 216 O CYS A 203 SHEET 1 AA9 4 THR B 5 GLN B 6 0 SHEET 2 AA9 4 ALA B 19 ARG B 24 -1 O ARG B 24 N THR B 5 SHEET 3 AA9 4 ASP B 71 ILE B 76 -1 O ILE B 76 N ALA B 19 SHEET 4 AA9 4 PHE B 63 GLY B 65 -1 N SER B 64 O THR B 75 SHEET 1 AB1 2 SER B 12 LEU B 13 0 SHEET 2 AB1 2 GLU B 106 ILE B 107 1 O GLU B 106 N LEU B 13 SHEET 1 AB2 5 SER B 54 ARG B 55 0 SHEET 2 AB2 5 PRO B 45 TYR B 50 -1 N TYR B 50 O SER B 54 SHEET 3 AB2 5 LEU B 34 GLN B 39 -1 N TRP B 36 O LEU B 48 SHEET 4 AB2 5 CYS B 89 GLN B 91 -1 O GLN B 90 N ALA B 35 SHEET 5 AB2 5 THR B 98 PHE B 99 -1 O THR B 98 N GLN B 91 SHEET 1 AB3 2 VAL B 86 TYR B 87 0 SHEET 2 AB3 2 THR B 103 LYS B 104 -1 O THR B 103 N TYR B 87 SHEET 1 AB4 3 PHE B 117 PHE B 119 0 SHEET 2 AB4 3 VAL B 134 PHE B 140 -1 O VAL B 134 N PHE B 119 SHEET 3 AB4 3 TYR B 174 LEU B 176 -1 O TYR B 174 N PHE B 140 SHEET 1 AB5 2 VAL B 147 TRP B 149 0 SHEET 2 AB5 2 CYS B 195 VAL B 197 -1 O GLU B 196 N GLN B 148 SSBOND 1 CYS C 336 CYS C 361 1555 1555 2.03 SSBOND 2 CYS C 379 CYS C 432 1555 1555 2.03 SSBOND 3 CYS C 391 CYS C 525 1555 1555 2.03 SSBOND 4 CYS C 480 CYS C 488 1555 1555 2.03 SSBOND 5 CYS A 22 CYS A 96 1555 1555 2.03 SSBOND 6 CYS A 147 CYS A 203 1555 1555 2.03 SSBOND 7 CYS B 23 CYS B 89 1555 1555 2.03 SSBOND 8 CYS B 135 CYS B 195 1555 1555 2.03 LINK ND2 ASN C 343 C1 NAG C 601 1555 1555 1.44 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000